Determination of the Incidence of Endometriosis and or Adenomyosis in Patients Diagnosed With Polycystic Ovary Syndrome, or the Incidence of Polycystic Ovary Syndrome in Patients Diagnosed With Endometriosis and or Adenomyosis

NCT04916171 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2450

Last updated 2022-08-11

No results posted yet for this study

Summary

The study was designed as a multicenter, prospective cross-sectional cohort study. The research population will consist of patients under the age of 40, diagnosed with endometriosis and/or adenomyosis and polycystic ovary syndrome, who applied to the obstetrics and gynecology outpatient clinics in 13 centers. According to the results of the sample size analysis, it was planned to terminate the study when 1225 patients with polycystic ovary syndrome and 1225 patients with endometriosis and/or adenomyosis were recruited.

Conditions

  • Endometriosis
  • Polycystic Ovary Syndrome
  • Adenomyosis

Interventions

OTHER

incidence

It is aimed to determine the incidence of endometriosis and/or adenomyosis in patients diagnosed with polycystic ovary syndrome, or to determine the incidence of polycystic ovary syndrome in patients diagnosed with endometriosis and/or adenomyosis.

Sponsors & Collaborators

  • Engin Oral

    collaborator UNKNOWN
  • Berna Dilbaz

    collaborator UNKNOWN
  • Gürkan Bozdag

    collaborator UNKNOWN
  • Cem Atabekoğlu

    collaborator UNKNOWN
  • Nuray Bozkurt

    collaborator UNKNOWN
  • Gokce Anik Ilhan

    collaborator UNKNOWN
  • Ali Kolusari

    collaborator UNKNOWN
  • Cihan Kaya

    collaborator UNKNOWN
  • Banu Yılmaz

    collaborator UNKNOWN
  • Engin Yildirim

    collaborator UNKNOWN
  • Ahmet Başar Tekin

    collaborator UNKNOWN
  • Servet Ozden hacivelioglu

    collaborator UNKNOWN
  • Kanuni Sultan Suleyman Training and Research Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2022-12-31
Completion
2023-01-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04916171 on ClinicalTrials.gov